Huntington National Bank’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
NAMA
Huntington National Bank's PACB Position: Q2 2026 in Review
Huntington National Bank increased its Pacific Biosciences (PACB) stake by 248,000% in Q2 2026, buying an estimated $3.61K and bringing the position to 2,481 shares worth $4.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.
Huntington National Bank first reported a position in PACB in Q3 2018 and has held it in 31 quarters since. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Huntington National Bank held 2,481 shares of Pacific Biosciences worth $4.17K as of Q2 2026.
- Huntington National Bank bought 2,480 Pacific Biosciences shares in Q2 2026, an estimated $3.61K.
- Pacific Biosciences made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2291 holding.
- Huntington National Bank first reported a position in Pacific Biosciences in Q3 2018 and has held it in 31 quarters since.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.